LPL Financial’s Tema Oncology ETF CANC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.73M Buy
138,824
+36,548
+36% +$1.38M ﹤0.01% 2670
2026
Q1
$3.75M Buy
102,276
+94,258
+1,176% +$3.43M ﹤0.01% 2896
2025
Q4
$278K Buy
+8,018
New +$262K ﹤0.01% 5204

Other funds holding CANC

LPL Financial's CANC Position: Q2 2026 in Review

LPL Financial increased its Tema Oncology ETF (CANC) stake by 36% in Q2 2026, buying an estimated $1.38M and bringing the position to 138,824 shares worth $5.73M. The position accounts for ﹤0.01% of the portfolio, ranked #2670.

LPL Financial first reported a position in CANC in Q4 2025 and has held it in 3 quarters since. 15 funds tracked by Wall St. Rank hold CANC as of Q2 2026.

  • LPL Financial held 138,824 shares of Tema Oncology ETF worth $5.73M as of Q2 2026.
  • LPL Financial bought 36,548 Tema Oncology ETF shares in Q2 2026, an estimated $1.38M.
  • Tema Oncology ETF made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #2670 holding.
  • LPL Financial first reported a position in Tema Oncology ETF in Q4 2025 and has held it in 3 quarters since.
  • 15 funds tracked by Wall St. Rank held Tema Oncology ETF as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.